Ausgabe 2/2010
Inhalt (8 Artikel)
Reduced-Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis
Haefaa Alchalby, Nicolaus Kröger
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
Robert A. Kyle, S. Vincent Rajkumar
Tyrosine Kinase Inhibitors: The First Decade
Meetu Agrawal, Ravin J. Garg, Jorge Cortes, Alfonso Quintás-Cardama
Targeting Chronic Myeloid Leukemia Stem Cells
G. Vignir Helgason, Graham A. R. Young, Tessa L. Holyoake
Molecular Monitoring of BCR-ABL Transcripts in Patients With Chronic Myelogenous Leukemia: Is High Sensitivity of Clinical Value?
Maxim Norkin, Charles A. Schiffer
Levels of Care: Defining Best Supportive Care in Elderly Patients with Acute Myeloid Leukemia
Ellen K. Ritchie, Gail J. Roboz
Acute Myeloid Leukemia: When to Transplant in First Complete Remission
Brian T. Hill, Edward A. Copelan
The Role of Molecular Tests in Acute Myelogenous Leukemia Treatment Decisions
Gabriela Motyckova, Richard M. Stone